BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9266138)

  • 1. To treat or not to treat? Current attitudes on treatment aimed at modifying the disease burden in clinically suspect arthralgia: a survey among participants of the TREAT EARLIER trial and healthcare professionals.
    Krijbolder DI; Khidir SJH; van der Helm-van Mil AH
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37532468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatoid arthritis: assessing disease activity and outcome.
    Symmons DP
    Clin Med (Lond); 2010 Jun; 10(3):248-51. PubMed ID: 20726456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint Damage Over Time in Patients With Early Rheumatoid Arthritis Follows Trajectories Related to Distinct Courses of Disease Activity.
    Dumoulin QA; Verstappen M; van der Helm-van Mil AHM; van Steenbergen HW
    J Rheumatol; 2023 Apr; 50(4):573-575. PubMed ID: 36319022
    [No Abstract]   [Full Text] [Related]  

  • 4. Meta-analysis of long-term joint structural deterioration in minimally treated patients with rheumatoid arthritis.
    Jansen JP; Vieira MC; Bradley JD; Cappelleri JC; Zwillich SH; Wallenstein GV
    BMC Musculoskelet Disord; 2016 Aug; 17(1):348. PubMed ID: 27538585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.
    Chighizola CB; Ong VH; Meroni PL
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):401-423. PubMed ID: 27515671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
    Sarzi-Puttini P; D'Ingianna E; Fumagalli M; Scarpellini M; Fiorini T; Chérié-Lignière EL; Panni B; Fiorentini F; Corbelli V; Beyene NB; Mastaglio C; Severi C; Locati M; Cazzola M; Menozzi G; Monti G; Saccardo F; Alfieri G; Atzeni F
    Rheumatol Int; 2005 Jan; 25(1):15-22. PubMed ID: 14530867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis.
    Albers JM; Paimela L; Kurki P; Eberhardt KB; Emery P; van 't Hof MA; Schreuder FH; Leirisalo-Repo M; van Riel PL
    Ann Rheum Dis; 2001 May; 60(5):453-8. PubMed ID: 11302866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of understanding radiographic findings in relation to clinical outcomes in rheumatoid arthritis.
    Keystone EC
    J Rheumatol Suppl; 2009 Jun; 82():11-6. PubMed ID: 19509325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclosporin on joint damage in rheumatoid arthritis. The Italian Rheumatologists Study Group on Rheumatoid Arthritis.
    Ferraccioli GF; Bambara LM; Ferraris M; Perpignano G; Cattaneo R; Porzio F; Accardo S; Mattara L; Zoppini A; Benucci M; Ostuni PA; Pasero G
    Clin Exp Rheumatol; 1997; 15 Suppl 17():S83-9. PubMed ID: 9266138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
    Suzuki Y; Wakabayashi T; Saito E; Suwa A
    Clin Calcium; 2007 Apr; 17(4):546-52. PubMed ID: 17404484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study.
    Korpela M; Laasonen L; Hannonen P; Kautiainen H; Leirisalo-Repo M; Hakala M; Paimela L; Blåfield H; Puolakka K; Möttönen T;
    Arthritis Rheum; 2004 Jul; 50(7):2072-81. PubMed ID: 15248204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis.
    Motomura H; Matsushita I; Seki E; Mine H; Kimura T
    Int J Rheum Dis; 2014 Sep; 17(7):749-54. PubMed ID: 24251619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
    Ciubotariu E; Gabay C; Finckh A;
    J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.
    Pasero G; Priolo F; Marubini E; Fantini F; Ferraccioli G; Magaro M; Marcolongo R; Oriente P; Pipitone V; Portioli I; Tirri G; Trotta F; Della Casa-Alberighi O
    Arthritis Rheum; 1996 Jun; 39(6):1006-15. PubMed ID: 8651963
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.